Literature DB >> 10631933

Class I MHC molecules: assembly and antigen presentation.

J C Solheim1.   

Abstract

Several years ago, the only factor known to be necessary for the assembly and surface expression of class I MHC was beta 2m; even for beta 2m, it was unclear at what point in class I maturation its role was played. Recent experiments that employed attachment of an endoplasmic reticulum (ER) retention signal to beta 2m have shown that the point of time at which beta 2m is required is while the class I heavy chain is in the ER. Later association between beta 2m and class I is not vital in order for properly folded class I to be expressed at the cell surface. After crystallization of the first class I MHC molecule, it was realized that not only is antigen presented by class I, but that antigen is presented in the form of a peptide that stabilizes the class I structure and allows its transit to the cell surface. Class I allelic differences influence interactions with both peptide and beta 2m, with likely consequences for the ability of the class I heavy chains to present antigen through alternative pathways. Furthermore, it is now also clear that formation of appropriate disulfide bonds in the class I heavy chain is needed before class I can bind peptide antigen securely, a process that may be assisted by an ER chaperone. Many different proteins that are resident in the ER, such as calnexin, transporter associated with antigen processing (TAP), calreticulin, and tapasin, have been found to be integral to class I assembly. TAP, tapasin, and calreticulin bind preferentially to the open form of class I, which can be distinguished with the use of a monoclonal antibody specific for this form. Calreticulin and calnexin contrast in their interactions with class I, despite other similarities between these two chaperones. Overall, class I MHC assembly is now understood to involve the interplay of multiple intra- and intermolecular events in a defined chronological order which ensure continual reporting of cellular contents to cytotoxic T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10631933     DOI: 10.1111/j.1600-065x.1999.tb01352.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  13 in total

Review 1.  Expression of nonclassical MHC class Ib genes: comparison of regulatory elements.

Authors:  T Kevin Howcroft; Dinah S Singer
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

2.  Expression of calreticulin is associated with infiltration of T-cells in stage IIIB colon cancer.

Authors:  Rui-Qing Peng; Ying-Bo Chen; Ya Ding; Rong Zhang; Xing Zhang; Xing-Juan Yu; Zhi-Wei Zhou; Yi-Xin Zeng; Xiao-Shi Zhang
Journal:  World J Gastroenterol       Date:  2010-05-21       Impact factor: 5.742

Review 3.  RANK-mediated signaling network and cancer metastasis.

Authors:  Gina Chia-Yi Chu; Leland W K Chung
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

Review 4.  Minor histocompatibility antigens--targets of graft versus leukemia responses.

Authors:  Stanley R Riddell; M Murata; S Bryant; E H Warren
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

5.  How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene.

Authors:  M Chatterjee-Kishore; K L Wright; J P Ting; G R Stark
Journal:  EMBO J       Date:  2000-08-01       Impact factor: 11.598

6.  Neuronal MHC class I molecules are involved in excitatory synaptic transmission at the hippocampal mossy fiber synapses of marmoset monkeys.

Authors:  Adema Ribic; Mingyue Zhang; Christina Schlumbohm; Kerstin Mätz-Rensing; Barbara Uchanska-Ziegler; Gabriele Flügge; Weiqi Zhang; Lutz Walter; Eberhard Fuchs
Journal:  Cell Mol Neurobiol       Date:  2010-03-16       Impact factor: 5.046

7.  The serum levels of soluble interleukin-2 receptor alpha and lactate dehydrogenase but not of B2-microglobulin correlate with selected clinico-pathological prognostic factors and response to therapy in childhood soft tissue sarcomas.

Authors:  Ewa Bien; Malgorzata Rapala; Malgorzata Krawczyk; Anna Balcerska
Journal:  J Cancer Res Clin Oncol       Date:  2009-08-20       Impact factor: 4.553

8.  Development of a cytokine-modified allogeneic whole cell pancreatic cancer vaccine.

Authors:  Dan Laheru; Barbara Biedrzycki; Elizabeth M Jaffee
Journal:  Methods Mol Biol       Date:  2013

9.  The expression patterns of MHC class I molecules in the developmental human visual system.

Authors:  Aifeng Zhang; Hong Yu; Yuqing Shen; Jiane Liu; Youji He; Qian Shi; Bo Fu; Fengqin Miao; Jianqiong Zhang
Journal:  Neurochem Res       Date:  2012-11-04       Impact factor: 3.996

10.  Effective RNAi-mediated β2-microglobulin loss of function by transgenesis in Xenopus laevis.

Authors:  Hristina Nedelkovska; Eva-Stina Edholm; Nikesha Haynes; Jacques Robert
Journal:  Biol Open       Date:  2013-01-29       Impact factor: 2.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.